BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CytoPharm 

6F, No. 6, Sec. 1, Jung-Shing Road
Wugu Shiang
Taipei      Taiwan
Phone: 02-8976-9628 Fax: 02-8976-95629


SEARCH JOBS




Industry
Pharmaceutical






 Company News
CytoPharm and Amarillo Biosciences (AMAR) Announce Positive HCV Study Results: Oral Interferon Found to Reverse Thrombocytopenia; Reduced Relapse Rate Seen in Patients With Mild Fibrosis 6/15/2012 7:50:48 AM
Amarillo Biosciences (AMAR) and CytoPharm Announce Start of Enrollment for Hepatitis C Study in Taiwan 6/29/2009 10:59:20 AM
Amarillo Biosciences (AMAR) Partner CytoPharm Approved to Enroll 165 Patient Phase 2 Hepatitis C Trial in Taiwan 2/13/2009 9:52:49 AM
Amarillo Biosciences (AMAR) Signs Deal with CytoPharm of Taiwan 3/25/2008 1:28:38 PM
Amarillo Biosciences (AMAR) Enters Into a License and Supply Agreement With CytoPharm for Low Dose Oral Interferon Use in Animal Diseases in China and Taiwan 3/25/2008 9:56:34 AM
Amarillo Biosciences (AMAR) Partner, CytoPharm, to Conduct 144 Patient Phase 2 Hepatitis C Trial in Taiwan 2/19/2008 10:16:07 AM
CytoPharm to Conduct Hepatitis C Trial and Seek Regulatory Approval for Amarillo Biosciences (AMAR)' Low Dose Oral Interferon 5/31/2007 1:05:33 PM